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Use of a Novel Portable Three-Dimensional Imaging System to Measure Limb Volume and
Circumference in Patients with Filarial Lymphedema
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Gary J. Weil,3 and Philip J. Budge3*
1
Filariasis Research Training and Service Unit, Faculty of Medicine, University of Ruhuna, Galle, Sri Lanka; 2LymphaTech, Atlanta, Georgia;
Infectious Diseases Division, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri; 4George W. Woodruff
School of Mechanical Engineering, Parker H. Petit Institute of Biotechnology and Bioscience, Georgia Institute of Technology, Atlanta, Georgia
3

Abstract. The World Health Organization’s Global Program to Eliminate Lymphatic Filariasis (LF) has reduced LF
transmission worldwide, but millions remain affected by ﬁlarial lymphedema. Tools for clinically monitoring lymphedema
in developing nations are limited. We tested a novel, portable, infrared three-dimensional imaging system (3DIS) against
water displacement (WD) and tape measurement of limb circumference (TMLC) among patients with ﬁlarial leg lymphedema in Galle, Sri Lanka. Outcomes were accuracy and reproducibility of imaging system measurements. In parallel,
we also tested the reproducibility of skin thickness ultrasound (STU) measurements. We examined 52 patients (104 limbs)
with lymphedema of stages 0–6 (N = 28, 19, 20, 21, 2, 4, and 10, respectively). 3DIS measurements correlated nearly
perfectly with WD (r2 = 0.9945) and TMLC values (r2 > 0.9801). The median time required to acquire imaging system
measurements for both legs was 2.1 minutes, compared with 17, 7, and 29 minutes, respectively, for WD, TMLC, and STU.
Median interexaminer coefﬁcients of variation (CVs) for volume measurements were 1.1% (interquartile range [IQR]
0.5–2.1%) for WD and 1.7% (IQR 1.2–2.4%) for the 3DIS. CVs for circumference measurements were 1.4% (IQR
0.8–2.4%) by TMLC and 1.3% (0.8–1.9%) by 3DIS. Median interexaminer CV for STU was 13.7% (IQR 8.5–21.3%). The
portable imaging system noninvasively provided accurate and reproducible limb volume and circumference measurements in approximately 2 minutes per patient. This portable technology has the potential to greatly improve assessment
and monitoring of lymphedema in the clinic and in the ﬁeld.

system developed for limb geometry measurement and
has been used to monitor lymphedema. 9 Other techniques using stereophotogrammetry and infrared structured light depth sensors from XBOX Kinect ™ (Microsoft
Corporation, Redmond, WA) have also been reported.10–13
However, these techniques are limited by large hardware
requirements and/or limited accuracy, and this has prevented their widespread use. Recently, LymphaTech, Inc.
(Atlanta, GA) developed a novel lymphedema measuring and
monitoring tool that uses a 3D infrared depth sensor integrated into a computer tablet with custom software. Given
the need for improved methods of measuring lymphedema in
ﬁlariasis patients, we tested this technology in patients with
ﬁlarial lower extremity lymphedema to determine whether it
could produce accurate and reproducible limb geometry
measurements suitable for monitoring disease progression
or improvement over time.

INTRODUCTION
Lymphatic ﬁlariasis (LF) is a debilitating, mosquito-borne, parasitic infection that causes hydroceles and disﬁguring lymphedema in millions of patients worldwide. Since its initiation in 2000,
the World Health Organization’s Global Program to Eliminate LF
(GPELF) has achieved remarkable success in reducing LF transmission through mass drug administration (MDA),1 which has
cured millions and prevented over 80 million new infections.2
Unfortunately, MDA does not usually reverse lymphedema in
those already affected, and there is a great need for expanded and
improved strategies for reducing LF-related morbidity.
Efforts to study lymphedema are hampered by the difﬁculty
of measuring its severity and monitoring changes over time.
The seven-stage system of lymphedema severity developed
by Dreyer et al.3 is clinically useful, but as a noncontinuous
scale it is difﬁcult to use as an outcome in clinical trials. The
gold standard for measuring limb volume is water displacement (WD),4,5 but this method is cumbersome and impractical
for use in ﬁeld studies. Tape measures of limb circumference
(TMLC) are frequently used, but can be difﬁcult to standardize and do not predict volume adequately for lower
extremity lymphedema.6,7 Ultrasound can be used to measure
the thickness of skin and soft tissues over the malleolus (skin
thickness ultrasound [STU]),8 but this method requires expensive equipment and adequate training, and it is difﬁcult to
standardize.
Three-dimensional (3D) optical imaging is a promising new
technology for lymphedema measurement and monitoring.
An opto-electronic device called Perometer® (Pero-System
Messgeraete, Wuppertal, Germany) was the ﬁrst infrared-based

MATERIALS AND METHODS
Ethics statement. The study protocol was reviewed and
approved by the institutional review board at the Washington
University School of Medicine and the Ethical Review Committee, Faculty of Medicine, University of Ruhuna in Sri Lanka.
Printed participant information sheets and written consent
forms were provided to participants in Sinhalese. Written
consent was obtained from all participants who were eligible
for this study (age ³ 18 years).
Patient population and setting. Volunteers with varying
stages of limb lymphedema were recruited from among those
receiving care at the Filariasis Research Training and Service
Unit (FRTSU), Faculty of Medicine, in Galle, Sri Lanka. Patients
were contacted by mail or phone and offered the opportunity
to participate. Interested patients presented to the FRTSU
clinic between March 20 and 31, 2017, for enrollment and
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measurements. Adults with any stage of lymphedema were
eligible to participate.
Study procedures. Six examiners were trained to perform
WD, TMLC, STU, and 3D imaging system (3DIS) lymphedema
measurements during the ﬁrst 2 days of the study period
(March 20–31, 2017) with nine patient volunteers. Training day
measurements were not included in the data analysis. Study
measures and examination methods are shown in Table 1.
TMLC, STU, and 3DIS measures were performed by three
separate examiners per patient. WD was performed twice per
patient, as we found it impractical to perform thrice per patient
during the training period. Examiners recorded a start time and
stop time for each examination so that the cumulative time
needed for each could be reported. In this article, we deﬁne an
“examination” as the measurement of both legs from one
patient by one examiner. However, most patients with unilateral lymphedema had only the affected limb (stages 1–6) examined by STU. In such cases, the examination time for STU of
one limb was doubled to provide a time estimate for a
complete (bilateral) examination.
WD was measured using a rectangular water tank ﬁtted with
a drainage spout at a height of 32 cm above the inner base of
the tank. The tank was ﬁlled until water drained from the spout
and was allowed to drip to cessation. The patient placed his/
her leg inside a disposable, transparent, watertight cellophane
bag and immersed the leg in the tank (Figure 1C). The patient
stood with the knee of the measured limb straight until
water stopped dripping from the spout. Patients with trouble
balancing could hold a nearby countertop for support. The
displaced water volume was measured using standard
graduated cylinders (2 L, 500 mL, or 250 mL). This procedure
was performed on both legs of each patient by two independent examiners. Start time for WD began after the
water tank had equilibrated, and examination duration included the time it took to measure the ﬁrst leg, re-equilibrate
the tank, and then measure the second leg. Some examiners
also included the time it took to reset the tank after measurement of the second leg (completing the cycle), but this
was not uniformly done, so the mean examination times
reported represent at least the time taken to measure both

legs and reset the tank once, but less than the complete
cycle time.
TMLC was measured around the foot at 10 cm proximal to
the great toe and around the leg at heights of 12, 24, and 36 cm
above the ﬂoor while the patient sat with the knee directly
above the ankle.14 For the foot measurement, a line on the
surface on which the foot rested marked 10 cm from the tip of
the great toe. The examiner marked the medial and lateral
sides of the foot where they crossed this line and then aligned
a tape measure to those markings to measure the circumference. For the leg measurements, a height pole positioned
parallel to the leg from the knee to the ankle malleolus was
used to mark the correct height on the medial and lateral sides
of each leg (Figure 1B), and circumference was measured by
positioning a tape measure around the marks. Three examiners independently measured each leg; the marks were wiped
off the skin between each examination.
Ankle STU measurements were performed essentially as
described by Mand et al.,8 using a linear transducer (L12-4,
Phillips Healthcare, Bothel, WA) connected to an 8-inch S2
tablet (Samsung Electronics America, Inc., Ridgeﬁeld Park,
NJ) equipped with the downloadable Phillips Lumify app
(Phillips Healthcare). The patient sat or reclined on an examination table with the knee extended and the toes pointing
upward. Holding the transducer parallel to the table and perpendicular to the leg, the examiner located the malleolus by
scanning along the leg to the narrowest distance between the
skin surface and the tibia (medial) or ﬁbula (lateral) (Figure 1A).
The examiner then brought the tendon sheath posterior to the
malleolus into view (tibialis posterior on the medial side, peroneal tendon sheath on the lateral side); with this marker in
view, the examiner captured the image and measured the
distance between the skin surface and the malleolus using the
software calipers. Each examiner took four measurements
over each malleolus (repositioning the probe and capturing a
new image each time to give independent measurements),
and each patient was examined by three separate examiners.
For each site, the four measures of each individual examiner
were compared to determine intraobserver variability. The
individual measures were then averaged and the averages

TABLE 1
Study measurements and examination methods
Parameter

Water displacement

Tape measure limb
circumference

Skin thickness
ultrasound (STU)

Three-dimensional
imaging system

Examiners per participant
Examinations per participant per examiner
Total examinations per patient
Number of measurements per examination
Leg volume (ﬂoor to 32 cm height)
Circumference measurements
Foot (10 cm from the tip of the great toe)
Leg, 12 cm height
Leg, 24 cm height
Leg, 36 cm height
Skin thickness over the malleolus
Left lateral
Left medial
Right medial
Right lateral
Intraexaminer comparison*
Interexaminer comparison†

2
1
2

3
1
3

3
1
3

3
2
6

1

–

–

1

–
–
–
–

1
1
1
1

–
–
–
–

–
1
1
1

–
–
–
–
No
Yes

–
–
–
–
No
Yes

4
4
4
4
Yes
Yes

–
–
–
–
Yes
Yes

* For STU, variability among the four replicate measurements at each site was assessed; for the 3D imaging system variability between the ﬁrst and second examinations of each examiner.
† The four replicate measurements for each STU examination were averaged and the mean was compared between examinations. All 3D imaging system measurements for each patient,
regardless of examiner, were included.
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FIGURE 1. Study measurements: (A) skin thickness ultrasound, (B) limb circumference, (C) water displacement volume, and (D) three-dimensional
imaging system. This ﬁgure appears in color at www.ajtmh.org.

from each of the separate examiners compared to determine
interobserver variability. Because of the time burden of performing STU, we did not perform STU on most stage 0 (unaffected) limbs.
The 3DIS (LymphaTech) combines an infrared depth sensor
with a tablet computer using proprietary software. The system
integrates 3D depth data acquired from the sensor with accelerometer data from the tablet to perform real-time point
cloud fusion, producing complete point cloud reconstructions
with submillimeter resolution. Custom software extracts speciﬁc limb volume and circumference measurements. The 3DIS
procedure starts with the patient standing in the center of an
open space with his/her feet approximately shoulder-width
apart. The examiner stands 2–3 feet away from the patient and
points the tablet camera at the patient’s legs. A sizing box
superimposed on the tablet screen’s live camera view is adjusted to set the data capture window for the depth sensor. As
the examiner walks in a circle around the standing patient to
capture visual data (Figure 1D, Supplemental Video 1), the
tablet screen shows a 3D model acquisition overlaid on the
image of the leg so that the examiner can verify adequate data
capture. The examiner ensures that the entire surface of both
legs is captured, then stops data capture and views the 3D
reconstruction of the patient’s limbs, rotating the image to ensure it contains no gaps or artifactual distortions (Figure 2). For
this study examiners captured data from just above a patient’s
knees to the ﬂoor, and the imaging system software calculated
limb volume from the ﬂoor to a height of 32 cm and leg circumference measurements at heights of 12, 24, and 36 cm,
from the 3D model. Each patient was imaged twice by each of
three separate examiners. An example of the 3D point-cloud
model generated by the imaging system can be viewed online
(Supplemental Video 2).
Data capture and analysis. WD, STU, and TMLC measurements were recorded on paper forms and transcribed into
an MS Excel database. Transcribed data were independently

checked against the primary data forms by a second reviewer.
3DIS data were electronically transferred to MS Excel. All
analyses were performed in Stata, version 12.1 (College Station, TX). Means and standard deviations are reported for data
that were normally distributed (skew between −1.0 and 1.0).
Medians and interquartile range (IQR) are reported for skewed
data. Because most data were not normally distributed, we
used the Kruskal–Wallis test and the Wilcoxon rank-sum test
to determine statistical signiﬁcance for group or pairwise comparisons, respectively. Replicate measurements from each examiner were averaged and compared across examiners to
generate interexaminer coefﬁcients of variation (CVs).
RESULTS
Fifty-two patients with varying stages of lymphedema were
examined. The median time required to acquire 3DIS measurements of both legs was 2.1 minutes, compared with 17, 7,
and 29 minutes, respectively, for WD, TMLC, and STU
( Table 2).
Accuracy of 3DIS. Limb volume and circumference measurements obtained by 3DIS were highly accurate and tightly
correlated with WD and TMLC measurements (r2 > 0.98,
Figure 3). Linear regression correlation coefﬁcients (and 95%
conﬁdence intervals) obtained by comparing 3DIS estimates
with mean WD and TMLC measurements at 12, 24, and 36 cm
heights were 1.02 (1.01–1.02), 0.99 (0.98–0.99), 0.97
(0.96–0.98), and 0.95 (0.94–0.97), respectively. A coefﬁcient of
1.00 would indicate exact agreement between 3DIS and
comparator measurements.
Intraexaminer variability. Intraexaminer CVs for 3DIS
measurements ranged from 0% to 4.9% and varied by examiner and lymphedema stage. Median CVs for 3DIS volume
measurements (1.1%, IQR 0.5–2.1%) were somewhat higher
than those for 3DIS circumference measurements (0.8%,
IQR 0.4–1.3%; P < 0.001). Intraexaminer CVs for STU ranged
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FIGURE 2. Reconstructions created by the three-dimensional (3D) imaging system. (A) Photos and imaging system reconstructions from patients
with different stages of lymphedema. (B) One patient’s point-cloud reconstruction, demonstrating how the model can be rotated and analyzed for
circumference measures. A video of a rotating 3D model showing the level of detail captured can be viewed online (Supplemental Video 2). This
ﬁgure appears in color at www.ajtmh.org.

from 0.2% to 39.9%, with a median of 4.8% (IQR 2.9–8.0%),
and also varied by examiner and lymphedema stage
(Supplemental Table 1). Because WD and TMLC were
measured only once per examiner per patient, no intraexaminer comparisons for these measurements were
possible.
Interexaminer variability. Interexaminer variability for all
methods is shown in Figure 4. Median interexaminer CVs were
not signiﬁcantly different between the 3DIS and TMLC measurements at 12 cm and 36 cm, but they were lower at 24 cm
for the 3DIS (1.3%, IQR 0.8–1.9%) than for TMLC measurements (2.0%, IQR 1.0–3.1%; P = 0.0001). CVs for TMLC at

24 cm were also slightly but signiﬁcantly higher than each of
the other TMLC measurements (Supplemental Table 2). Median interexaminer CVs for TMLC of the foot was 1.2% (IQR
0.7–2.0%), but this could not be compared with 3DIS because
the imaging system software could not provide foot circumference measurements. For limb volume measurements,
median interexaminer CVs for the 3DIS (1.7%, IQR 1.2–2.4%)
were slightly higher than for WD (1.2%, IQR 0.5–2.1%; P =
0.0001). In no interexaminer comparison did the 3DIS CV exceed 6%, whereas some CV values exceeded 10% for all
other measures. STU was the only modality for which interexaminer variability differed by stage (Supplemental

TABLE 2
The number of patients and limbs examined, and time required per examination
Water displacement
(WD)

Patients examined
Total limbs examined
Stage of examined limbs
Stage 0
Stage 1
Stage 2
Stage 3
Stage 4
Stage 5
Stage 6
Total examinations performed*
Number of examinations timed
Minutes required per examination,
median (IQR)†

49
98
26
18
20
19
2
3
10
94
92
17 (14.5–20)

Tape measures of limb circumference
(TMLC)

Skin thickness ultrasound
(STU)

Three-dimensional imaging system
(3DIS)

49
98

52
74

49
98

26
18
20
19
2
3
10
147
145
7 (6–8)

1
19
20
21
2
4
7
154
152
29 (25–34)

26
18
20
19
2
3
10
287
268
2.1 (1.7–2.4)

IQR = interquartile range.
* Not all patients completed all intended examinations; four patients declined a second WD examination, four patients received only two (rather than three) STU examinations because of time
constraints, and four patients had one or more 3DIS examinations unintentionally skipped by the study team (one patient received 3 of 6, one 4 of 6, and two 5 of 6). For STU, 70 examinations included
both legs and 84 included only one because most unaffected (stage 0) limbs were not measured by STU.
† For STU examinations that included only one leg, the examination time was doubled so that all values approximate the time required to measure both legs.
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FIGURE 3. Correlation of three-dimensional imaging system measurements with water displacement (A) or with tape measurements of
limb circumference (TMLC) at heights of 12 cm (B), 24 cm (C), and 36
cm (D). Gray shading around the regression line indicates 95% conﬁdence intervals for the regression. This ﬁgure appears in color at
www.ajtmh.org.

Table 2), with stages 5 and 6 having signiﬁcantly lower
CVs than stages 0–4 (median 9.2% versus 15.2%, P =
0.0004). A linear regression of interexaminer CV versus
mean skin thickness conﬁrmed that STU was signiﬁcantly
less variable at greater skin thicknesses (regression
coefﬁcient −4.0, 95% conﬁdence interval −6.1 to −1.9).
DISCUSSION
While much of the attention of GPELF has focused on reducing LF transmission through MDA, the program also aims
to improve morbidity management for persons with clinically
evident ﬁlariasis. The latter activity will last long after transmission of the infection has been interrupted. Improved
methods for assessing and monitoring changes in ﬁlarial
lymphedema are needed to improve clinical management of
patients and for clinical trials that assess the impact of new
treatments or management strategies. In addition, methods
capable of reliably detecting small volume changes might
help identify patients needing therapy earlier, preventing
progression to advanced disease. A major study documented an impressive regression of lymphedema in some
ﬁlariasis patients after doxycycline treatment,8 and additional studies are planned to conﬁrm this important ﬁnding
(ClinicalTrials.gov Identiﬁers: NCT02929134, NCT02927496,
NCT02929121). Part of the motivation for the current study
came from a desire to use the best possible outcome measures
in these trials.
Each examination method used in our study had different
strengths and weaknesses. WD was the most reliable but also
the slowest method assessed; it was also difﬁcult to use in
patients with advanced lymphedema. Some patients with very
large limbs required assistance to lift their leg into the tank, and
occasionally water spilled from the tank that could not be

FIGURE 4. Interexaminer variability for each examination method is
shown in Panel A. Panel B compares variability obtained with the
three-dimensional imaging system (3DIS) (in green) with variability
observed with tape measures of limb circumference (TMLC) at different levels and water displacement (WD) (orange). The two highest
CV outliers for TMLC shown in panel A were foot measurements.
There was no 3DIS comparison for this TMLC measurement and that is
why this comparison is not shown in panel B. STU = skin thickness
ultrasound. This ﬁgure appears in color at www.ajtmh.org.

measured. Patients also had difﬁculty standing still for the
several minutes it took for water to completely drain from the
tank during limb measurement. As a result, three patients with
stage 5 or 6 lymphedema in our study could only tolerate a
single WD examination. The time required to reset the tank
after each examination also contributed to the long examination times.
TMLC was easier for the patients but less reliable than
WD, and it was relatively labor and time intensive. The use of
a pole to mark height measurements on both the medial
and lateral sides of each leg increased reproducibility and
decreased the risk of measuring oblique circumferences. As
expected, irregular contours seem to increase the difﬁculty
of obtaining reproducible measurements. TMLC was statistically less reliable at the 24 cm height, a height at which
the curvature of the calf muscle is prominent. In addition, the
highest outliers were seen among foot circumference
measurements, presumably because the irregular anatomy
of the foot makes it difﬁcult to ensure that the measurement
is performed at the same angle and at exactly 10 cm from the
tip of the great toe each time.

USE OF A NOVEL PORTABLE 3D IMAGING SYSTEM TO MEASURE FILARIAL LYMPHEDEMA

STU was the most difﬁcult method to standardize. None of
the examiners were trained radiologists or ultrasound technicians. Although a standard operating procedure (SOP) was
taught, it did not address every contingency, especially for
patients with atypical anatomy. The higher interexaminer
versus intraexaminer variability suggests that examiners developed their own habits for dealing with these uncertainties.
In addition, examiners were not blinded to their own replicate
measurements and may have been biased to obtain replicate
values that matched their initial measurement. By contrast,
examiners were blinded to measurements of other examiners,
making interobserver variability a more meaningful outcome in
our study. Probe positioning habits likely contributed to high
interexaminer variability. For example, examiners were taught
to deliberately decompress the skin after ﬁnding the STU
markers, but it is difﬁcult to know how effectively this was
done. Improved training, a more comprehensive SOP, and the
use of formally trained ultrasonographers would likely reduce
STU variability, but this would also make it less practical for
use in resource-limited settings.
The infrared 3DIS had several advantages and few limitations compared with the other methods studied. It was essentially equivalent to TMLC and WD in terms of accuracy and
reproducibility, but much faster, providing volume and circumference measurements for both legs in less than onetenth of the combined time required for WD and TMLC. The
3DIS does not require physical contact with the patient, which
is important for patients with skin ulcers or infected wounds
that are common in patients with advanced lymphedema. To
reduce the risk of infection and contamination of equipment,
we did not obtain TMLC or STU measurements over open
wounds, and we used disposable plastic bags to cover limbs
during WD. None of these precautions were necessary for 3D
imaging. The primary limitation of the 3DIS in our study was
that image-derived circumference measurements at the
36 cm height had to be discarded for four patients whose
clothing obscured the leg surface (the examiner failed to ensure that the patient’s legs were bare up to the knee). Similar to
WD, the 3DIS requires that patients stand still to obtain accurate measurements, but this limitation is offset by the speed
of the process and by software that prompts the examiner to
abort and restart the examination if patient movements are
detected. Although each patient was imaged twice by each of
the three examiners, no patients in our study declined imaging
because of difﬁculty in tolerating the procedure.
One potential limitation of the 3DIS for widespread use in
ﬁlariasis is cost. It is not clear what the cost of the system will
be once the manufacturer brings the device to market, but the
total cost of the hardware (computer tablet, infrared sensor)
used in this study was approximately $1,300, which does not
include software development and licensing costs or support.
Assuming that the market price will be higher than the hardware costs, it may be difﬁcult for clinics in extremely resourcelimited settings to acquire a system without external support.
On the other hand, the current cost is relatively low compared
with that of other clinical laboratory technologies. It may also
be possible to further reduce costs if the system software can
be modiﬁed for use on personal tablets or smartphones and
distributed through an app store. Another limitation of the
3DIS in this study was the inability to take foot circumference measurements. This is because the manufacturer had
not yet created software algorithms for extrapolating foot
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circumference measurements, although such software is in
development. Given the accuracy of the imaging system’s
volume measurements, which include the volume of the
foot, it seems highly likely that accurate foot circumference
and/or dedicated foot volume measurements should also
be possible with updated image processing code. Although
the lack of dedicated foot measurements was a limitation of
3DIS measurements for this study, it also illustrates the
ﬂexibility of the technique. Once the point-cloud model is
acquired, it requires only the appropriate software code to
extrapolate any number of potential additional measurements. In this study, we chose to extrapolate leg volume
with a cutoff of 32 cm height and circumference measurements at 12, 24, and 36 cm height to match the WD and
TMLC measurements. In future studies, however, any number of circumference or volume measurements might be
extracted, including foot circumference, breadth, and height of
the foot dorsum, etc., with appropriate modiﬁcation of the
scanner software currently under development.
To our knowledge, this is the ﬁrst time that infrared 3D imaging
technology has been used in patients with ﬁlarial lymphedema,
and the results are highly encouraging. The 3DIS provided estimates of limb volume and circumference that were highly correlated with global standard methods (WD and TMLC) for patients
with a wide range of limb sizes and varying stages of lymphedema. The intra- and interexaminer variability for 3DIS measurements were very low and comparable with those observed with
WD. However, 3D imaging is much faster and more feasible for
use in clinical or ﬁeld settings than WD, particularly when one
considers that a single 2- to 3-minute scan can generate both
volume and any desired circumference measurements. Ninetyﬁve percent of interexaminer comparisons for the 3DIS had CV
values less than 3.3%, and all were less than 6%, suggesting
that this technology should be able to reliably detect true
changes in limb volume or circumference of 6% or more with a
high degree of conﬁdence. Although these results require
conﬁrmation, it appears that this novel 3D imaging technology
will greatly improve our ability to accurately assess and monitor
changes in leg lymphedema over time in the clinic and in the
ﬁeld.
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